10/15/2026
Playoff-caliber enrollment from Kansas! ⚾🧡
Kansas Gastroenterology and Wichita Urology have enrolled FOUR more patients in the BOOM-IBD2 pivotal trial in the last eight days. Now that’s a winning streak!
BOOM-IBD2 is the first-ever pivotal trial of a neuromodulation device in inflammatory bowel disease. Ulcerative colitis affects millions of people and profoundly impacts their daily lives.
And, to the patients who chose to participate, THANK YOU!
Learn more about the trial — link in comments.
Kansas Gastroenterology, Wichita Urology